Reuters exclusively reportes EU in talks with Moderna, BioNtech, CureVac to secure possible COVID vaccines

Reuters exclusively reported that the European Union is negotiating advance purchase deals of potential COVID-19 vaccines with drugmakers Moderna, Sanofi and Johnson & Johnson as well as biotech firms BioNtech and CureVac. The talks follow a deal reached in June by four EU member states with AstraZeneca for the upfront purchase of 400 million doses of its potential COVID-19 vaccine, in principle available to all 27 EU nations. The multiple talks confirm the bloc’s more assertive stance on procuring potential COVID-19 shots and drugs after early U.S. moves in securing promising treatments and vaccines.

Article Tags
Topics of Interest: DealsHealth
Type: Reuters Best
Sectors: Equities
Regions: Europe
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text